SOCS1 and hepatocellular carcinoma: In this context, SOCS1-deficient HCC cells, which upregulate NRF2-mediated and possibly other antioxidant defense mechanisms, could be rendered susceptible to chemotherapeutic agents that increase ROS production if their elevated antioxidant mechanisms could be simultaneously suppressed.